• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROLLENIUM MEDICAL TECHNOLOGIES INC., REVANESSE VERSA; NOT CONFIRMED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROLLENIUM MEDICAL TECHNOLOGIES INC., REVANESSE VERSA; NOT CONFIRMED Back to Search Results
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problems Deposits (1809); Nodule (4551)
Event Type  Injury  
Manufacturer Narrative
The manufacturer is attempting to get in touch with the clinic to obtain more information regarding treatment for a medical expert review.
 
Event Description
The nurse injector reported that the patient was injected with revanesse versa into the marionette lines.Patient has hard rock like accumulations that started 2 months after treatment.Patient was previously injected in the same area with juvederm vollure in june.The manufacturer is attempting to obtain preliminary treatment information form the patient for an expert medical review.The importer facility person of contact has provided the clinic's np with information on treatment on treating delayed onset nodules.
 
Manufacturer Narrative
(b)(6) 2022, qa has forwarded a notification letter to the clinic to convey the necessity of providing adequate information to enable adequate investigations.No information was provided.A medical assessment could not be made with the limited information provided.Manufacturer has decided to close the case.
 
Event Description
Based on the information provided by the nurse injector, the patient was injected with revanesse versa in the marionette lines.Patient has hard rock like accumulations that started 2 months after treatment.Patient was previously injected in the same area with juvederm vollure in june.The manufacturer is attempting to obtain preliminary treatment information form the patient for an expert medical review.The manufacturer could not obtain further information from the clinic despite repeated attempts.(b)(6) 2022, qa has forwarded a notification letter to the clinic to convey the necessity of providing adequate information to enable adequate investigations.No information was provided.A medical assessment could not be made with the limited information provided.Manufacturer has decided to close the case.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REVANESSE VERSA; NOT CONFIRMED
Type of Device
REVANESSE VERSA; NOT CONFIRMED
Manufacturer (Section D)
PROLLENIUM MEDICAL TECHNOLOGIES INC.,
138 industrial parkway n
aurora, ontario L4G 4 C3
CA  L4G 4C3
Manufacturer (Section G)
PROLLENIUM MEDICAL TECHNOLOGIES INC.,
138 industrial parkway north
aurora, ontario L4G 4 C3
CA   L4G 4C3
Manufacturer Contact
ario khohsbin
138 industrial parkway north
aurora, ontario L4G 4-C3
CA   L4G 4C3
MDR Report Key11400326
MDR Text Key234331424
Report Number3004423487-2021-00003
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P160042/S003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility
Reporter Occupation Nurse Practitioner
Remedial Action Patient Monitoring
Type of Report Initial,Followup
Report Date 10/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/02/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Date Manufacturer Received02/02/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-